Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer Disease”

378 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 378 results

Large-scale testing (Phase 3)Temporarily pausedNCT04520412
What this trial is testing

Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 2,046
Testing effectiveness (Phase 2)Study completedNCT03520998
What this trial is testing

Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild to Moderate Alzheimer Disease
Alkahest, Inc. 47
Testing effectiveness (Phase 2)Ended earlyNCT02085265
What this trial is testing

Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Sunnybrook Health Sciences Centre 23
Testing effectiveness (Phase 2)Study completedNCT02947893
What this trial is testing

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Georgetown University 37
Large-scale testing (Phase 3)Study completedNCT02017340
What this trial is testing

A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Prof Brian Lawlor 511
Not applicableStudy completedNCT01796314
What this trial is testing

Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life

Who this might be right for
Alzheimer Disease
University Hospital, Toulouse 170
Large-scale testing (Phase 3)Study completedNCT04669028
What this trial is testing

NE3107 in Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
BioVie Inc. 439
Testing effectiveness (Phase 2)Study completedNCT00566397
What this trial is testing

Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 402
Testing effectiveness (Phase 2)Active Not RecruitingNCT06881836
What this trial is testing

ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ono Pharmaceutical Co., Ltd. 240
Large-scale testing (Phase 3)Ended earlyNCT00937352
What this trial is testing

A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 896
Large-scale testing (Phase 3)Study completedNCT00053599
What this trial is testing

Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA) 400
Testing effectiveness (Phase 2)Study completedNCT03748706
What this trial is testing

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Pain Therapeutics 13
Early research (Phase 1)Study completedNCT00397891
What this trial is testing

Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 80
Early research (Phase 1)Study completedNCT02386306
What this trial is testing

Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GliaCure, Inc. 39
Not applicableStudy completedNCT05433493
What this trial is testing

Effect of Individual Cognitive Stimulation on Memory and Executive Function in Older Adults With Alzheimer's Disease

Who this might be right for
DementiaNeurocognitive DisordersCognitive Impairment+2 more
Rsocialform - Geriatria, Lda 142
Testing effectiveness (Phase 2)Study completedNCT00810147
What this trial is testing

A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 209
Not applicableUnknownNCT05251649
What this trial is testing

Transcranial Alternating Current Stimulation Combined With 40Hz Sound Stimulation for Treatment Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00876863
What this trial is testing

Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sangamo Therapeutics 49
Early research (Phase 1)Study completedNCT02434718
What this trial is testing

Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 21
Testing effectiveness (Phase 2)Study completedNCT00722046
What this trial is testing

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 198
Load More Results